stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Corbus Pharmaceuticals Holdings IncCRBP
$2.0615.61%-0.38

Corbus Pharmaceuticals Holdings Inc (CRBP)

Corbus Pharmaceuticals Holdings Inc stock is traded at $2.06, with a volume of 1,044,601. It is down -15.61% in the last 24 hours and down -53.51% over the past month. Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
Previous Close:
$2.44
Open:
$2.43
24h Volume:
1,044,601
Relative Volume:
1.36
Market Cap:
$42.35M
Revenue:
$1.54M
Net Income/Loss:
-$84.53M
P/E Ratio:
-
EPS:
-$5.81
Net Cash Flow:
-$73.65M
1W Performance:
-39.38%
1M Performance:
-53.51%
6M Performance:
-78.88%
1Y Performance:
-82.42%
1-Day Range:
$2.05$2.48
1-Week Range:
$2.05$3.62
52-Week Range:
$2.05$12.88

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile

Name
Corbus Pharmaceuticals Holdings Inc
Phone
617-963-0103
Address
500 RIVER RIDGE DRIVE, NORWOOD, MA, USA
Employee
36
Next Earnings Date
-
Latest SEC Filings
SEC
CRBP's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Financials Data

Similar to CRBP